TrialHaematologica2012

Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post-remission therapy in older adults with previously untreated acute myeloid leukemia.

Roland B Walter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.